RxDoctor Payments Data

Kathleen Witkowski

Adult Health · Arlington, VANPI 1841546983

Payments from drug & device makers

$2,588in general payments, 2019–2025

Across 41 payments — averaging $63.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CTI Biopharma Corp.$700
  • Johnson & Johnson$668
  • Novartis$194
  • Beone Medicines USA, Inc.$129
  • Ipsen Biopharmaceuticals, Inc$125
  • Incyte Corporation$100
  • plus $671 from 16 others

What the payments were for

  • Consulting fees$49519%
  • Speaking & faculty fees$70027%
  • Food & beverage$1,17145%
  • Education$2239%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,588 in reported general payments places this provider in the 75th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$100,859
Medicare patients
171
Services billed
3,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib16$244,920
EliquisApixaban37$32,543
CreonLipase/Protease/Amylase13$22,934
Hydroxyurea29$780
Acyclovir30$545
Gabapentin41$485
Potassium Chloride28$458
Warfarin Sodium22$262
Oxycodone Hcl17$190
Prochlorperazine Maleate21$190
Pantoprazole Sodium15$145
Levothyroxine Sodium14$128
Nystatin13$126
Prednisone29$122
Tramadol Hcl12$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$32,54337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 368 adult health providers in Virginia.

Other adult health in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →